Intrinsiqs

Is Johnson & Johnson overvalued?

Johnson & Johnson (JNJ) looks overvalued — trading about 23% above its fair value.

Overvalued
Current price $285.75 Fair value $219.55
Price
$285.75
Fair value
$219.55
Current P/E
25.9
Normal P/E
19.9
Market cap
$687.89B
Dividend yield
1.9%
Return on equity
19.6%
Sector
Healthcare

See the full interactive analysis →

Fair value compares JNJ's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 15 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.NVS Novartis AG